Debu Tripathy, MD is Professor of Medicine and Co-Leader of the Women's Cancer Program and he holds the Priscilla and Art Ulene Chair in Women’s Cancer. He received his medical degree and internal medicine residency at Duke University and Hematology/Oncology Fellowship at the University of California at San Francisco.
His area of clinical research interest is novel therapeutics in breast cancer, specifically, growth factor receptor pathway targeting as well as biomarkers that predict sensitivity and resistance. Elucidation of specific mechanisms of resistance and synthetic lethal combinatorial strategies from the laboratory are being applied for early phase therapeutic applications. Similarly, human tissue studies from patients receiving conventional and targeted therapies are being analyzed toward the discovery of novel targets.
Dr. Tripathy is also part of a trans-disciplinary team of breast cancer specialists dedicated to patient-centered state-of-the-art and personalized approaches to care, with an emphasis on clinical trials that interface with the basic scientific strengths at USC. Dr. Tripathy has published numerous original laboratory and clinical research articles in the area of breast cancer and serves on several editorial boards, study sections and societies. He has served as the President of the American Society of Breast Disease and the Society of Integrative Oncology.